Company Profile

Centessa Pharmaceuticals plc (NASDAQ: CNTA)
8:00 PM UTC, 06/20/25
Last: $12.43 Change: -0.25 %Change: -1.97% Volume: 1,612,616
Detailed Quote
Open: $ 12.87   Volume: 1,612,616
High: $ 13.02   Yield(%) 0.00
Low: $ 12.30   P/E Ratio (ttm): n/a
Dividend ($): n/a   Market Cap ($): 1.69B
EPS ($) -1.80   Shares Out: 133.55M
M = Million B = Billion
Price Performance
% Price Change (last 4 weeks): 0.48
% Price Change (last 13 weeks): -22.16
% Price Change (last 26 weeks): -27.75
% Price Change (last 52 weeks): 43.12
% Price Change (year to date): -24.30
Management Effectiveness
Return on Equity (%): -73.96
Return on Assets (%): -50.05
Return on Invested Capital (%): -69.43
Profitability
Gross Profit Margin (%): n/a
Net Profit Margin (%): n/a
Operating Profit Margin (%): 0.00
Price & Volume
50-day Moving Average: $12.60
200-day Moving Average: $15.28
Avg. Daily Vol. (last 50 days): 920,195
Avg. Daily Vol. (last 200 days): 810,326
52-wk high: $19.09
52-wk low: $8.46
Bid: $4.99
Ask: $14.23
Company Information
Centessa Pharmaceuticals Plc operates as clinical-stage pharmaceutical company, which engages in discovering and developing medicines that delivers transformational to patients. Its portfolio include preclinical to phase three uncorrelated programs spanning diseases with high unmet need across oncology, hematology, immunology, inflammation, neuroscience, and rare diseases. The company was founded on October 26, 2020 and is headquartered in Altrincham, the United Kingdom.
Centessa Pharmaceuticals plc
1 Ashley Road 3rd Floor
Altrincham CA WA14 2DT

Phone: 44.7391.789784
Fax: n/a
http://centessa.com
Per Share Data
Earnings (1year) ($): -1.80
Annual Dividend ($): 0.00
Current P/E Ratio (ttm): n/a
Book Value ($): 3.03
Cash Flow ($): -1.77
Valuation Ratios
Price/Earnings (x): n/a
Price/Sales (x): n/a
Price/Book (x): 5.53
Price/Cash Flow (x): n/a
Financial Strength
Quick Ratio (x): 9.25
Current Ratio (x): 9.25
LT Debt/Equity (x): 29.19
Total Debt/Equity (x): 29.19



Quotes displayed with 15 minutes delay. Market data provided by Factset. Powered and implemented by FactSet Digital Solutions. Legal Statement. News provided by MT Newswires, a Division of MidnightTrader, Inc. Events Data provided by Wall Street Horizon. ©2020 Wall Street Horizon, Inc.